

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle remodeling (GO:0034374) | 9.18811182 |
| 2 | glandular epithelial cell differentiation (GO:0002067) | 8.92212157 |
| 3 | intestinal epithelial cell development (GO:0060576) | 8.71895484 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 7.60505897 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 7.60505897 |
| 6 | bile acid and bile salt transport (GO:0015721) | 7.05219649 |
| 7 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 6.63714902 |
| 8 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 6.10179673 |
| 9 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 6.06682239 |
| 10 | endocrine pancreas development (GO:0031018) | 6.03888542 |
| 11 | lung secretory cell differentiation (GO:0061140) | 5.75829636 |
| 12 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 5.75488098 |
| 13 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.69225956 |
| 14 | phenol-containing compound catabolic process (GO:0019336) | 5.60062456 |
| 15 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.57631760 |
| 16 | regulation of chronic inflammatory response (GO:0002676) | 5.47573829 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 5.12406603 |
| 18 | columnar/cuboidal epithelial cell development (GO:0002066) | 5.12249252 |
| 19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.98724187 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.96325393 |
| 21 | cellular response to type I interferon (GO:0071357) | 4.96325393 |
| 22 | COPII vesicle coating (GO:0048208) | 4.93624130 |
| 23 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.93318349 |
| 24 | response to type I interferon (GO:0034340) | 4.89779133 |
| 25 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.87212780 |
| 26 | protein maturation by protein folding (GO:0022417) | 4.85010935 |
| 27 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.84137991 |
| 28 | regulation of interferon-alpha production (GO:0032647) | 4.77061824 |
| 29 | response to peptidoglycan (GO:0032494) | 4.66395003 |
| 30 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.57817896 |
| 31 | peptide hormone processing (GO:0016486) | 4.54158326 |
| 32 | signal peptide processing (GO:0006465) | 4.49841108 |
| 33 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.39861360 |
| 34 | regulation of vitamin metabolic process (GO:0030656) | 4.38587286 |
| 35 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.32519385 |
| 36 | positive regulation of heat generation (GO:0031652) | 4.29405165 |
| 37 | phosphatidylserine metabolic process (GO:0006658) | 4.29213569 |
| 38 | regulation of fever generation (GO:0031620) | 4.22500660 |
| 39 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 4.20357617 |
| 40 | sulfation (GO:0051923) | 4.13003144 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 4.10349445 |
| 42 | cerebellar Purkinje cell layer development (GO:0021680) | 4.08852799 |
| 43 | nucleotide transmembrane transport (GO:1901679) | 4.08798490 |
| 44 | intestinal absorption (GO:0050892) | 4.05073030 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.03042914 |
| 46 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 4.00614890 |
| 47 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.97297791 |
| 48 | insulin secretion (GO:0030073) | 3.96499237 |
| 49 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.95543145 |
| 50 | type B pancreatic cell development (GO:0003323) | 3.89154037 |
| 51 | defense response to protozoan (GO:0042832) | 3.84383958 |
| 52 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.84147550 |
| 53 | regulation of chemokine biosynthetic process (GO:0045073) | 3.82864223 |
| 54 | positive regulation of cell fate commitment (GO:0010455) | 3.80792420 |
| 55 | glandular epithelial cell development (GO:0002068) | 3.80603557 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 3.79555141 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 3.78900725 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.75747045 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.75747045 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.75747045 |
| 61 | germinal center formation (GO:0002467) | 3.73349710 |
| 62 | response to protozoan (GO:0001562) | 3.72619430 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.71721588 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.71270115 |
| 65 | positive regulation of type 2 immune response (GO:0002830) | 3.69965322 |
| 66 | myeloid dendritic cell differentiation (GO:0043011) | 3.67403915 |
| 67 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63872274 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.63857175 |
| 69 | T-helper 1 type immune response (GO:0042088) | 3.61959000 |
| 70 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.60411804 |
| 71 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.58095832 |
| 72 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57911617 |
| 73 | positive regulation of insulin secretion (GO:0032024) | 3.56038228 |
| 74 | negative regulation of viral genome replication (GO:0045071) | 3.55504851 |
| 75 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.54240593 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.51399290 |
| 77 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.49001816 |
| 78 | response to hepatocyte growth factor (GO:0035728) | 3.49001816 |
| 79 | vesicle coating (GO:0006901) | 3.46199663 |
| 80 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.45516291 |
| 81 | alditol phosphate metabolic process (GO:0052646) | 3.44816954 |
| 82 | bile acid metabolic process (GO:0008206) | 3.44086583 |
| 83 | inner ear receptor cell development (GO:0060119) | 3.43510408 |
| 84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.42278296 |
| 85 | protein targeting to Golgi (GO:0000042) | 3.41703713 |
| 86 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.41149130 |
| 87 | positive regulation of nuclease activity (GO:0032075) | 3.40978440 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 3.39918010 |
| 89 | regulation of T-helper cell differentiation (GO:0045622) | 3.39907676 |
| 90 | neurotransmitter catabolic process (GO:0042135) | 3.39599825 |
| 91 | regulation of immunoglobulin secretion (GO:0051023) | 3.39337685 |
| 92 | negative regulation of amino acid transport (GO:0051956) | 3.37703684 |
| 93 | catecholamine biosynthetic process (GO:0042423) | 3.37652328 |
| 94 | catechol-containing compound biosynthetic process (GO:0009713) | 3.37652328 |
| 95 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.35954780 |
| 96 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.34785769 |
| 97 | GDP-mannose metabolic process (GO:0019673) | 3.33219236 |
| 98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33149157 |
| 99 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.32905917 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 3.32309346 |
| 101 | keratinocyte development (GO:0003334) | 3.31067267 |
| 102 | digestive system process (GO:0022600) | 3.30793768 |
| 103 | regulation of insulin secretion (GO:0050796) | 3.30426079 |
| 104 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.29449476 |
| 105 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.28668548 |
| 106 | negative regulation of norepinephrine secretion (GO:0010700) | 3.28427050 |
| 107 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.28239128 |
| 108 | regulation of heat generation (GO:0031650) | 3.27391613 |
| 109 | negative regulation of cell fate commitment (GO:0010454) | 3.26926080 |
| 110 | granulocyte activation (GO:0036230) | 3.25167045 |
| 111 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24375499 |
| 112 | modulation by symbiont of host defense response (GO:0052031) | 3.24375499 |
| 113 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24375499 |
| 114 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24375499 |
| 115 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24375499 |
| 116 | modulation by symbiont of host immune response (GO:0052553) | 3.24375499 |
| 117 | phosphatidic acid biosynthetic process (GO:0006654) | 3.24030109 |
| 118 | phosphatidic acid metabolic process (GO:0046473) | 3.24030109 |
| 119 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.23156979 |
| 120 | regulation of type 2 immune response (GO:0002828) | 3.22328817 |
| 121 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.22069216 |
| 122 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.21818772 |
| 123 | regulation of growth of symbiont in host (GO:0044126) | 3.21818772 |
| 124 | negative regulation of growth of symbiont in host (GO:0044130) | 3.21818772 |
| 125 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.21818772 |
| 126 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.20652655 |
| 127 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18993875 |
| 128 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.15780841 |
| 129 | myeloid dendritic cell activation (GO:0001773) | 3.15581644 |
| 130 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.14253843 |
| 131 | digestion (GO:0007586) | 3.12946373 |
| 132 | ER overload response (GO:0006983) | 3.12877266 |
| 133 | regulation of mononuclear cell migration (GO:0071675) | 3.12173497 |
| 134 | response to muramyl dipeptide (GO:0032495) | 3.10529844 |
| 135 | cellular response to lipopolysaccharide (GO:0071222) | 3.09932674 |
| 136 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.08857453 |
| 137 | activation of MAPKKK activity (GO:0000185) | 3.08642032 |
| 138 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07931632 |
| 139 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.07376889 |
| 140 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.07047954 |
| 141 | regulation of antigen processing and presentation (GO:0002577) | 3.07042845 |
| 142 | regulation of nuclease activity (GO:0032069) | 3.06738806 |
| 143 | positive regulation of interferon-beta production (GO:0032728) | 3.06333507 |
| 144 | epithelial structure maintenance (GO:0010669) | 3.05008250 |
| 145 | positive regulation of interleukin-6 production (GO:0032755) | 3.04895391 |
| 146 | N-acetylglucosamine metabolic process (GO:0006044) | 3.04804175 |
| 147 | negative regulation of catecholamine secretion (GO:0033604) | 3.04575650 |
| 148 | nitric oxide mediated signal transduction (GO:0007263) | 3.04533455 |
| 149 | exocrine pancreas development (GO:0031017) | 3.04385526 |
| 150 | cellular response to molecule of bacterial origin (GO:0071219) | 3.04211351 |
| 151 | detection of other organism (GO:0098543) | 3.04050706 |
| 152 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.01645541 |
| 153 | * regulation of peptide hormone secretion (GO:0090276) | 2.99075737 |
| 154 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98567119 |
| 155 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.97892194 |
| 156 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.97828148 |
| 157 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.97804510 |
| 158 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.96946451 |
| 159 | positive regulation of defense response to virus by host (GO:0002230) | 2.96149771 |
| 160 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.96148511 |
| 161 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.95666733 |
| 162 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.95576029 |
| 163 | peptide hormone secretion (GO:0030072) | 2.95443052 |
| 164 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.95118027 |
| 165 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.94578351 |
| 166 | * regulation of peptide secretion (GO:0002791) | 2.94326990 |
| 167 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92179159 |
| 168 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.91923874 |
| 169 | positive regulation of interleukin-12 production (GO:0032735) | 2.91794606 |
| 170 | detection of molecule of bacterial origin (GO:0032490) | 2.91788384 |
| 171 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91373344 |
| 172 | positive regulation of peptide hormone secretion (GO:0090277) | 2.90660566 |
| 173 | monocyte chemotaxis (GO:0002548) | 2.90245474 |
| 174 | dendritic cell differentiation (GO:0097028) | 2.90048276 |
| 175 | interferon-gamma secretion (GO:0072643) | 2.89911253 |
| 176 | cellular response to interferon-alpha (GO:0035457) | 2.88961931 |
| 177 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.88587464 |
| 178 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.88433332 |
| 179 | plasma lipoprotein particle organization (GO:0071827) | 2.88386753 |
| 180 | cellular response to interferon-gamma (GO:0071346) | 2.87888589 |
| 181 | cellular response to unfolded protein (GO:0034620) | 2.86119945 |
| 182 | intestinal cholesterol absorption (GO:0030299) | 2.86102347 |
| 183 | negative regulation of cell killing (GO:0031342) | 2.85729947 |
| 184 | regulation of podosome assembly (GO:0071801) | 2.85656588 |
| 185 | peptide secretion (GO:0002790) | 2.84957879 |
| 186 | sequestering of metal ion (GO:0051238) | 2.84885414 |
| 187 | norepinephrine metabolic process (GO:0042415) | 2.84350769 |
| 188 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.83762917 |
| 189 | phosphatidylglycerol metabolic process (GO:0046471) | 2.82853398 |
| 190 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.82806997 |
| 191 | positive regulation of peptide secretion (GO:0002793) | 2.81819068 |
| 192 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.80558791 |
| 193 | glucosamine-containing compound metabolic process (GO:1901071) | 2.80253855 |
| 194 | protein-lipid complex subunit organization (GO:0071825) | 2.79658642 |
| 195 | establishment of protein localization to Golgi (GO:0072600) | 2.76988015 |
| 196 | regulation of microtubule-based movement (GO:0060632) | 2.74523875 |
| 197 | cellular response to nutrient (GO:0031670) | 2.73882141 |
| 198 | cellular response to topologically incorrect protein (GO:0035967) | 2.72145184 |
| 199 | protein retention in ER lumen (GO:0006621) | 2.71092541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.08588402 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.46310988 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.62873144 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.44935184 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.97944694 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.78177677 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76735856 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28318000 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.17460111 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10763297 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07181022 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04006722 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.01611308 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.00410172 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.77285011 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70269907 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.69963088 |
| 18 | STAT1_20625510_ChIP-Seq_HELA_Human | 2.57447581 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.48694991 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.46128256 |
| 21 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.44099994 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.42474254 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41340565 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.40046769 |
| 25 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.39822121 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39542846 |
| 27 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39109133 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.35014048 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31576511 |
| 30 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.11080897 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.11038341 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.08693186 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06564140 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.01399286 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96919417 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.96682376 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95722417 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.91754648 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89732383 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.87881679 |
| 41 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.83936561 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81280926 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81076879 |
| 44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.73391279 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72762584 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70310531 |
| 47 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.70271455 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70081452 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66508440 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66408497 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65739784 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.61646409 |
| 53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58961555 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.57949255 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56495746 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.55979221 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55554524 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55121874 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.54290777 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.53372685 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52687592 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.51958269 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51821384 |
| 64 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51000958 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50479444 |
| 66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.49656342 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49043724 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48317647 |
| 69 | SA1_27219007_Chip-Seq_Bcells_Human | 1.45560562 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45184236 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43812050 |
| 72 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.43662725 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41528175 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41066118 |
| 75 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.40129228 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40035274 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39729654 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.37754398 |
| 79 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.37388570 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37371999 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36408183 |
| 82 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35680638 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35595002 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35114968 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34797344 |
| 86 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.34683529 |
| 87 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34536997 |
| 88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.32803257 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32220008 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.31948977 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31798381 |
| 92 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31742719 |
| 93 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30897002 |
| 94 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.29852800 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29049599 |
| 96 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.27194754 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27163226 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26448452 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26390575 |
| 100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25395655 |
| 101 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24909010 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24626471 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21358369 |
| 104 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20853043 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20544134 |
| 106 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19381426 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18673895 |
| 108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18615066 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16799989 |
| 110 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.16326178 |
| 111 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16321690 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14160652 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13943960 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13868476 |
| 115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13683602 |
| 116 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13388589 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11517052 |
| 118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11105202 |
| 119 | MYB_26560356_Chip-Seq_TH1_Human | 1.10954967 |
| 120 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10883071 |
| 121 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10695073 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10036046 |
| 123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09789071 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09332429 |
| 125 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09182150 |
| 126 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08999228 |
| 127 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08781950 |
| 128 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08077590 |
| 129 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07734030 |
| 130 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07633157 |
| 131 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07570557 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07497129 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07315211 |
| 134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05429884 |
| 135 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05235579 |
| 136 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04159155 |
| 137 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03805322 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.02130972 |
| 139 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.01109746 |
| 140 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.01109746 |
| 141 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.01109746 |
| 142 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00402671 |
| 143 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00270376 |
| 144 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00084439 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99809723 |
| 146 | MAF_26560356_Chip-Seq_TH2_Human | 0.99626899 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99428276 |
| 148 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98930617 |
| 149 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97720784 |
| 150 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.97639340 |
| 151 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97426082 |
| 152 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.97136935 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97035707 |
| 154 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.96387528 |
| 155 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95727628 |
| 156 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95265382 |
| 157 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93656820 |
| 158 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.93584210 |
| 159 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93570266 |
| 160 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93251204 |
| 161 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93102033 |
| 162 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93020837 |
| 163 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92852373 |
| 164 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92833601 |
| 165 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91787726 |
| 166 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91652264 |
| 167 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91277230 |
| 168 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90428588 |
| 169 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89290262 |
| 170 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89231743 |
| 171 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88569607 |
| 172 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.87921986 |
| 173 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87640655 |
| 174 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87042000 |
| 175 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86568405 |
| 176 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85412889 |
| 177 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.84359126 |
| 178 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84350157 |
| 179 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81423429 |
| 180 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77328948 |
| 181 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76646391 |
| 182 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.76420050 |
| 183 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76214446 |
| 184 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74183668 |
| 185 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74139634 |
| 186 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72763125 |
| 187 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.70965133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 6.55314615 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 5.07853575 |
| 3 | MP0003724_increased_susceptibility_to | 4.80888459 |
| 4 | MP0003283_abnormal_digestive_organ | 4.66179312 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 4.66088303 |
| 6 | MP0010386_abnormal_urinary_bladder | 4.35169441 |
| 7 | MP0003183_abnormal_peptide_metabolism | 4.12550886 |
| 8 | MP0003436_decreased_susceptibility_to | 3.58350372 |
| 9 | MP0006082_CNS_inflammation | 3.57180924 |
| 10 | MP0002909_abnormal_adrenal_gland | 3.52879410 |
| 11 | MP0004043_abnormal_pH_regulation | 3.48434619 |
| 12 | MP0009785_altered_susceptibility_to | 3.47677942 |
| 13 | MP0002693_abnormal_pancreas_physiology | 3.44525447 |
| 14 | MP0004510_myositis | 3.43658410 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 3.35808004 |
| 16 | MP0000013_abnormal_adipose_tissue | 3.33791220 |
| 17 | MP0001835_abnormal_antigen_presentation | 3.26116860 |
| 18 | MP0001944_abnormal_pancreas_morphology | 3.07867125 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.81659982 |
| 20 | MP0002822_catalepsy | 2.80469789 |
| 21 | MP0001790_abnormal_immune_system | 2.79142510 |
| 22 | MP0005387_immune_system_phenotype | 2.79142510 |
| 23 | MP0004858_abnormal_nervous_system | 2.69303165 |
| 24 | MP0005671_abnormal_response_to | 2.63820089 |
| 25 | MP0005025_abnormal_response_to | 2.56079026 |
| 26 | MP0008004_abnormal_stomach_pH | 2.52258991 |
| 27 | MP0002419_abnormal_innate_immunity | 2.47129636 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 2.37384795 |
| 29 | MP0009764_decreased_sensitivity_to | 2.32725681 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 2.31844994 |
| 31 | MP0000678_abnormal_parathyroid_gland | 2.30000822 |
| 32 | MP0001533_abnormal_skeleton_physiology | 2.28648980 |
| 33 | MP0001666_abnormal_nutrient_absorption | 2.18786107 |
| 34 | MP0002723_abnormal_immune_serum | 2.18196974 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 2.15258768 |
| 36 | MP0001800_abnormal_humoral_immune | 2.13495892 |
| 37 | MP0003075_altered_response_to | 2.11832405 |
| 38 | MP0002452_abnormal_antigen_presenting | 2.10671288 |
| 39 | MP0004947_skin_inflammation | 2.08725661 |
| 40 | MP0003195_calcinosis | 2.08535173 |
| 41 | MP0004270_analgesia | 2.04725193 |
| 42 | MP0000462_abnormal_digestive_system | 2.03669000 |
| 43 | MP0009278_abnormal_bone_marrow | 2.03391358 |
| 44 | MP0002638_abnormal_pupillary_reflex | 2.00165080 |
| 45 | MP0003866_abnormal_defecation | 2.00127023 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.98753060 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.98705031 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.95804718 |
| 49 | MP0005365_abnormal_bile_salt | 1.86576126 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.85895136 |
| 51 | MP0000538_abnormal_urinary_bladder | 1.84893805 |
| 52 | MP0003252_abnormal_bile_duct | 1.82581315 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.81685431 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.80345965 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.78723901 |
| 56 | MP0001819_abnormal_immune_cell | 1.76398875 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.75241975 |
| 58 | MP0001853_heart_inflammation | 1.69687630 |
| 59 | MP0002254_reproductive_system_inflammat | 1.69309789 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.65264657 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.65264657 |
| 62 | MP0000343_altered_response_to | 1.63804877 |
| 63 | MP0005670_abnormal_white_adipose | 1.63380726 |
| 64 | MP0008469_abnormal_protein_level | 1.62038233 |
| 65 | MP0005451_abnormal_body_composition | 1.60921259 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.60834608 |
| 67 | MP0000685_abnormal_immune_system | 1.59033079 |
| 68 | MP0002405_respiratory_system_inflammati | 1.54233829 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.50332923 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.50019948 |
| 71 | MP0006054_spinal_hemorrhage | 1.47357777 |
| 72 | MP0009840_abnormal_foam_cell | 1.45804799 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 1.45600490 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 1.37469034 |
| 75 | MP0002733_abnormal_thermal_nociception | 1.36315287 |
| 76 | MP0003448_altered_tumor_morphology | 1.36310626 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.34975071 |
| 78 | MP0000477_abnormal_intestine_morphology | 1.33679683 |
| 79 | MP0005058_abnormal_lysosome_morphology | 1.32789197 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 1.32380220 |
| 81 | MP0001501_abnormal_sleep_pattern | 1.31034337 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.29072486 |
| 83 | MP0005166_decreased_susceptibility_to | 1.28478522 |
| 84 | MP0003690_abnormal_glial_cell | 1.27888368 |
| 85 | MP0000716_abnormal_immune_system | 1.25432827 |
| 86 | * MP0003868_abnormal_feces_composition | 1.25073147 |
| 87 | MP0001970_abnormal_pain_threshold | 1.24631068 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.24115576 |
| 89 | MP0003879_abnormal_hair_cell | 1.24104293 |
| 90 | * MP0003953_abnormal_hormone_level | 1.24059828 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 1.23043365 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 1.17948701 |
| 93 | MP0000858_altered_metastatic_potential | 1.17249244 |
| 94 | MP0010155_abnormal_intestine_physiology | 1.16272254 |
| 95 | MP0009643_abnormal_urine_homeostasis | 1.15852197 |
| 96 | MP0005076_abnormal_cell_differentiation | 1.15354001 |
| 97 | MP0001440_abnormal_grooming_behavior | 1.14875553 |
| 98 | MP0004885_abnormal_endolymph | 1.11041721 |
| 99 | MP0001542_abnormal_bone_strength | 1.09851581 |
| 100 | MP0002998_abnormal_bone_remodeling | 1.09091336 |
| 101 | MP0000604_amyloidosis | 1.08715939 |
| 102 | MP0005408_hypopigmentation | 1.08581706 |
| 103 | MP0008961_abnormal_basal_metabolism | 1.08342121 |
| 104 | MP0005164_abnormal_response_to | 1.08324974 |
| 105 | MP0002398_abnormal_bone_marrow | 1.08133941 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06767554 |
| 107 | MP0002229_neurodegeneration | 1.06665461 |
| 108 | * MP0005375_adipose_tissue_phenotype | 1.06213079 |
| 109 | MP0005310_abnormal_salivary_gland | 1.05838627 |
| 110 | MP0005360_urolithiasis | 1.05355686 |
| 111 | MP0001756_abnormal_urination | 1.03639199 |
| 112 | MP0009763_increased_sensitivity_to | 1.03556560 |
| 113 | MP0002837_dystrophic_cardiac_calcinosis | 1.02085027 |
| 114 | MP0005165_increased_susceptibility_to | 1.00786143 |
| 115 | MP0004133_heterotaxia | 1.00244813 |
| 116 | MP0001849_ear_inflammation | 1.00063553 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.96972314 |
| 118 | MP0005390_skeleton_phenotype | 0.96694022 |
| 119 | MP0003191_abnormal_cellular_cholesterol | 0.94905512 |
| 120 | MP0002429_abnormal_blood_cell | 0.93244754 |
| 121 | MP0000490_abnormal_crypts_of | 0.92767484 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.92695218 |
| 123 | MP0002751_abnormal_autonomic_nervous | 0.91831987 |
| 124 | MP0001529_abnormal_vocalization | 0.91730444 |
| 125 | MP0000613_abnormal_salivary_gland | 0.91336420 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.90721521 |
| 127 | MP0004883_abnormal_blood_vessel | 0.88930937 |
| 128 | MP0001986_abnormal_taste_sensitivity | 0.88847753 |
| 129 | MP0003646_muscle_fatigue | 0.87942424 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.87887637 |
| 131 | MP0005535_abnormal_body_temperature | 0.87792748 |
| 132 | MP0003656_abnormal_erythrocyte_physiolo | 0.87627689 |
| 133 | MP0002722_abnormal_immune_system | 0.87311424 |
| 134 | MP0004019_abnormal_vitamin_homeostasis | 0.87174455 |
| 135 | MP0003122_maternal_imprinting | 0.86512737 |
| 136 | MP0003091_abnormal_cell_migration | 0.83506909 |
| 137 | MP0000631_abnormal_neuroendocrine_gland | 0.82088433 |
| 138 | MP0003763_abnormal_thymus_physiology | 0.80176724 |
| 139 | MP0002928_abnormal_bile_duct | 0.78999428 |
| 140 | MP0001873_stomach_inflammation | 0.77295214 |
| 141 | * MP0005666_abnormal_adipose_tissue | 0.77068984 |
| 142 | MP0003119_abnormal_digestive_system | 0.75898902 |
| 143 | MP0008874_decreased_physiological_sensi | 0.75392519 |
| 144 | MP0005645_abnormal_hypothalamus_physiol | 0.73852611 |
| 145 | MP0000470_abnormal_stomach_morphology | 0.73136485 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.73064536 |
| 147 | * MP0002118_abnormal_lipid_homeostasis | 0.72380465 |
| 148 | MP0005266_abnormal_metabolism | 0.72307889 |
| 149 | MP0002933_joint_inflammation | 0.70801687 |
| 150 | MP0003634_abnormal_glial_cell | 0.70393519 |
| 151 | MP0000955_abnormal_spinal_cord | 0.69103211 |
| 152 | MP0003300_gastrointestinal_ulcer | 0.66244236 |
| 153 | MP0005023_abnormal_wound_healing | 0.66131729 |
| 154 | MP0004808_abnormal_hematopoietic_stem | 0.63681654 |
| 155 | MP0005647_abnormal_sex_gland | 0.61952747 |
| 156 | MP0001299_abnormal_eye_distance/ | 0.61703813 |
| 157 | MP0000249_abnormal_blood_vessel | 0.60500809 |
| 158 | MP0001851_eye_inflammation | 0.60183981 |
| 159 | MP0001764_abnormal_homeostasis | 0.59642665 |
| 160 | MP0010307_abnormal_tumor_latency | 0.58778593 |
| 161 | MP0000681_abnormal_thyroid_gland | 0.58723574 |
| 162 | MP0000920_abnormal_myelination | 0.57296351 |
| 163 | MP0001663_abnormal_digestive_system | 0.57216268 |
| 164 | MP0001485_abnormal_pinna_reflex | 0.56604864 |
| 165 | * MP0005334_abnormal_fat_pad | 0.55554160 |
| 166 | MP0005646_abnormal_pituitary_gland | 0.54676673 |
| 167 | MP0010352_gastrointestinal_tract_polyps | 0.54302824 |
| 168 | MP0003959_abnormal_lean_body | 0.53794118 |
| 169 | MP0003795_abnormal_bone_structure | 0.53590203 |
| 170 | MP0002572_abnormal_emotion/affect_behav | 0.52219471 |
| 171 | MP0001905_abnormal_dopamine_level | 0.51840816 |
| 172 | MP0008260_abnormal_autophagy | 0.51457066 |
| 173 | MP0003635_abnormal_synaptic_transmissio | 0.48854582 |
| 174 | MP0000639_abnormal_adrenal_gland | 0.48850520 |
| 175 | MP0005253_abnormal_eye_physiology | 0.48774946 |
| 176 | MP0001919_abnormal_reproductive_system | 0.48495846 |
| 177 | MP0000230_abnormal_systemic_arterial | 0.46709871 |
| 178 | MP0004859_abnormal_synaptic_plasticity | 0.45636846 |
| 179 | MP0004924_abnormal_behavior | 0.45151577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 6.71004965 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.71004965 |
| 3 | Orchitis (HP:0100796) | 6.49068305 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.76032102 |
| 5 | Stomatitis (HP:0010280) | 5.74435996 |
| 6 | Myositis (HP:0100614) | 5.72529453 |
| 7 | Hypoglycemic coma (HP:0001325) | 5.09028083 |
| 8 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.02881299 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.79995934 |
| 10 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.72772099 |
| 11 | Hypoglycemic seizures (HP:0002173) | 4.71217891 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 4.70326361 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.63523758 |
| 14 | Hypothermia (HP:0002045) | 4.63077829 |
| 15 | Symptomatic seizures (HP:0011145) | 4.61691848 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 4.40779345 |
| 17 | Keratoconjunctivitis (HP:0001096) | 4.31790010 |
| 18 | Dysostosis multiplex (HP:0000943) | 4.17504664 |
| 19 | Eczematoid dermatitis (HP:0000976) | 4.17166086 |
| 20 | Decreased circulating renin level (HP:0003351) | 4.12936027 |
| 21 | Recurrent abscess formation (HP:0002722) | 4.12885066 |
| 22 | Hyperparathyroidism (HP:0000843) | 4.10182437 |
| 23 | Loss of speech (HP:0002371) | 4.07945436 |
| 24 | Generalized aminoaciduria (HP:0002909) | 4.06961749 |
| 25 | Hyperglycemia (HP:0003074) | 4.05708152 |
| 26 | Menstrual irregularities (HP:0000858) | 4.05507791 |
| 27 | Disinhibition (HP:0000734) | 4.04073762 |
| 28 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.02015913 |
| 29 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.02015913 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 4.01166672 |
| 31 | Abnormal pancreas size (HP:0012094) | 3.95148655 |
| 32 | Ketoacidosis (HP:0001993) | 3.91142217 |
| 33 | Nuclear cataract (HP:0100018) | 3.90388745 |
| 34 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.84941642 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.81542578 |
| 36 | Mucopolysacchariduria (HP:0008155) | 3.81542578 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 3.60011149 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 3.58798467 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.58259227 |
| 40 | Late onset (HP:0003584) | 3.56958383 |
| 41 | Increased IgM level (HP:0003496) | 3.55795161 |
| 42 | Abdominal distention (HP:0003270) | 3.50928870 |
| 43 | Large for gestational age (HP:0001520) | 3.47514273 |
| 44 | Exocrine pancreatic insufficiency (HP:0001738) | 3.43065643 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.42982524 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.42982524 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.42982524 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 3.42622144 |
| 49 | Mutism (HP:0002300) | 3.42440459 |
| 50 | Gangrene (HP:0100758) | 3.40230919 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36453779 |
| 52 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.29625637 |
| 53 | Pulmonary infiltrates (HP:0002113) | 3.24691433 |
| 54 | Vasculitis (HP:0002633) | 3.19567615 |
| 55 | Hypsarrhythmia (HP:0002521) | 3.14106857 |
| 56 | Parakeratosis (HP:0001036) | 3.10965202 |
| 57 | Insulin resistance (HP:0000855) | 3.10261378 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 3.10158683 |
| 59 | Orthostatic hypotension (HP:0001278) | 3.07315224 |
| 60 | Bundle branch block (HP:0011710) | 3.07016744 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 3.06828483 |
| 62 | Unilateral renal agenesis (HP:0000122) | 3.05789514 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05525009 |
| 64 | Arterial thrombosis (HP:0004420) | 2.96794589 |
| 65 | Protuberant abdomen (HP:0001538) | 2.96083459 |
| 66 | Encephalitis (HP:0002383) | 2.95331681 |
| 67 | Progressive muscle weakness (HP:0003323) | 2.94383174 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 2.94369507 |
| 69 | Micronodular cirrhosis (HP:0001413) | 2.92409923 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.85583969 |
| 71 | Hypercortisolism (HP:0001578) | 2.85113020 |
| 72 | Hemoptysis (HP:0002105) | 2.84630553 |
| 73 | Glomerulonephritis (HP:0000099) | 2.80475115 |
| 74 | Oligomenorrhea (HP:0000876) | 2.79180878 |
| 75 | Hematochezia (HP:0002573) | 2.78915208 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78814303 |
| 77 | Purpura (HP:0000979) | 2.78759876 |
| 78 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.78669168 |
| 79 | Hypokalemia (HP:0002900) | 2.76040679 |
| 80 | Joint swelling (HP:0001386) | 2.72645186 |
| 81 | Decreased lacrimation (HP:0000633) | 2.72031522 |
| 82 | Agitation (HP:0000713) | 2.70662418 |
| 83 | Petechiae (HP:0000967) | 2.70035973 |
| 84 | Increased serum ferritin (HP:0003281) | 2.67306819 |
| 85 | Anorexia (HP:0002039) | 2.66147720 |
| 86 | Polyneuropathy (HP:0001271) | 2.66117341 |
| 87 | Hypoplastic ischia (HP:0003175) | 2.64020603 |
| 88 | Dysautonomia (HP:0002459) | 2.63454826 |
| 89 | Hypotension (HP:0002615) | 2.62215320 |
| 90 | Gout (HP:0001997) | 2.58979707 |
| 91 | Abnormality of renin-angiotensin system (HP:0000847) | 2.57128647 |
| 92 | Hyperactive renin-angiotensin system (HP:0000841) | 2.55279658 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.55155507 |
| 94 | Hypoplastic pelvis (HP:0008839) | 2.53557451 |
| 95 | Amyloidosis (HP:0011034) | 2.52661296 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.51683981 |
| 97 | Glycosuria (HP:0003076) | 2.51683981 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.50558237 |
| 99 | Increased IgE level (HP:0003212) | 2.49024419 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.47163078 |
| 101 | Basal ganglia calcification (HP:0002135) | 2.46480214 |
| 102 | Recurrent fungal infections (HP:0002841) | 2.45926137 |
| 103 | Recurrent viral infections (HP:0004429) | 2.45537343 |
| 104 | Vertigo (HP:0002321) | 2.45332364 |
| 105 | Autoimmune hemolytic anemia (HP:0001890) | 2.44411723 |
| 106 | Axonal loss (HP:0003447) | 2.43419064 |
| 107 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.43206642 |
| 108 | Abnormality of vitamin B metabolism (HP:0004340) | 2.40979155 |
| 109 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40760864 |
| 110 | Obstructive lung disease (HP:0006536) | 2.40760864 |
| 111 | Episodic fever (HP:0001954) | 2.40461269 |
| 112 | Meningitis (HP:0001287) | 2.40097618 |
| 113 | Gastrointestinal infarctions (HP:0005244) | 2.37334178 |
| 114 | Abnormality of the ischium (HP:0003174) | 2.36231325 |
| 115 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.35333843 |
| 116 | Neurofibrillary tangles (HP:0002185) | 2.34620310 |
| 117 | Acne (HP:0001061) | 2.34188685 |
| 118 | Abnormality of the pericardium (HP:0001697) | 2.33497405 |
| 119 | Osteomalacia (HP:0002749) | 2.33019899 |
| 120 | Pulmonary embolism (HP:0002204) | 2.32332014 |
| 121 | Recurrent skin infections (HP:0001581) | 2.31228172 |
| 122 | Keratitis (HP:0000491) | 2.30792673 |
| 123 | Nausea (HP:0002018) | 2.29222514 |
| 124 | Inappropriate behavior (HP:0000719) | 2.28796751 |
| 125 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.24880442 |
| 126 | Apathy (HP:0000741) | 2.24731383 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 2.22151953 |
| 128 | T lymphocytopenia (HP:0005403) | 2.21960919 |
| 129 | Gingivitis (HP:0000230) | 2.21249098 |
| 130 | Hepatosplenomegaly (HP:0001433) | 2.19388391 |
| 131 | Ketosis (HP:0001946) | 2.18348601 |
| 132 | Prolonged QT interval (HP:0001657) | 2.17457355 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 2.16736321 |
| 134 | Leukocytosis (HP:0001974) | 2.16198019 |
| 135 | Diminished motivation (HP:0000745) | 2.15403100 |
| 136 | Failure to thrive in infancy (HP:0001531) | 2.14924124 |
| 137 | Adrenal overactivity (HP:0002717) | 2.14416856 |
| 138 | Abnormal auditory evoked potentials (HP:0006958) | 2.14170025 |
| 139 | Pheochromocytoma (HP:0002666) | 2.13814819 |
| 140 | Abnormality of T cell number (HP:0011839) | 2.12290469 |
| 141 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.11854593 |
| 142 | Intrahepatic cholestasis (HP:0001406) | 2.11252790 |
| 143 | Glomerulopathy (HP:0100820) | 2.11185049 |
| 144 | Memory impairment (HP:0002354) | 2.10046190 |
| 145 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09609630 |
| 146 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09034926 |
| 147 | Abnormality of potassium homeostasis (HP:0011042) | 2.03709499 |
| 148 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03416310 |
| 149 | Arthralgia (HP:0002829) | 2.02468700 |
| 150 | Abnormality of lateral ventricle (HP:0030047) | 2.02203131 |
| 151 | Abnormality of the endocardium (HP:0004306) | 2.02093321 |
| 152 | Prolonged bleeding time (HP:0003010) | 2.01142792 |
| 153 | Hyperphosphaturia (HP:0003109) | 2.00746208 |
| 154 | Complement deficiency (HP:0004431) | 2.00354274 |
| 155 | Abnormal sex determination (HP:0012244) | 1.99837178 |
| 156 | Sex reversal (HP:0012245) | 1.99837178 |
| 157 | Abnormal protein glycosylation (HP:0012346) | 1.97448820 |
| 158 | Abnormal glycosylation (HP:0012345) | 1.97448820 |
| 159 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.97448820 |
| 160 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.97448820 |
| 161 | IgA deficiency (HP:0002720) | 1.96234878 |
| 162 | Neuroendocrine neoplasm (HP:0100634) | 1.95599481 |
| 163 | Urticaria (HP:0001025) | 1.94517635 |
| 164 | Abnormality of B cell number (HP:0010975) | 1.94257989 |
| 165 | Increased circulating renin level (HP:0000848) | 1.93771895 |
| 166 | Agnosia (HP:0010524) | 1.93613481 |
| 167 | Abnormal foot bone ossification (HP:0010675) | 1.91978790 |
| 168 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91254301 |
| 169 | Anhidrosis (HP:0000970) | 1.90639047 |
| 170 | Retinal atrophy (HP:0001105) | 1.88428511 |
| 171 | Neuronal loss in central nervous system (HP:0002529) | 1.88387975 |
| 172 | Cortical visual impairment (HP:0100704) | 1.84110202 |
| 173 | Fat malabsorption (HP:0002630) | 1.83762051 |
| 174 | Bradycardia (HP:0001662) | 1.83184990 |
| 175 | Global brain atrophy (HP:0002283) | 1.82426545 |
| 176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81474819 |
| 177 | Myocardial infarction (HP:0001658) | 1.80683614 |
| 178 | Malnutrition (HP:0004395) | 1.80324212 |
| 179 | Irritability (HP:0000737) | 1.79545075 |
| 180 | Back pain (HP:0003418) | 1.79321722 |
| 181 | Chronic bronchitis (HP:0004469) | 1.78508170 |
| 182 | Syncope (HP:0001279) | 1.78239705 |
| 183 | Hypokalemic alkalosis (HP:0001949) | 1.77469830 |
| 184 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76274556 |
| 185 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76274556 |
| 186 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76274556 |
| 187 | Disproportionate short-trunk short stature (HP:0003521) | 1.71976786 |
| 188 | Hyperkalemia (HP:0002153) | 1.69472579 |
| 189 | Xanthomatosis (HP:0000991) | 1.69445281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 7.33989678 |
| 2 | PASK | 4.79531506 |
| 3 | NME1 | 4.56533372 |
| 4 | FRK | 4.32127554 |
| 5 | INSRR | 3.68543964 |
| 6 | MAP3K14 | 3.14812182 |
| 7 | TAOK3 | 3.11585006 |
| 8 | TAOK2 | 3.11045820 |
| 9 | RPS6KB2 | 3.09342363 |
| 10 | IRAK4 | 2.96257885 |
| 11 | RIPK4 | 2.93226737 |
| 12 | RIPK1 | 2.89722715 |
| 13 | TBK1 | 2.85379231 |
| 14 | IKBKE | 2.52443348 |
| 15 | TYK2 | 2.48712190 |
| 16 | MAP3K2 | 2.30112680 |
| 17 | IKBKB | 2.26741023 |
| 18 | ERN1 | 2.24508479 |
| 19 | PIM2 | 2.22364253 |
| 20 | MOS | 2.20349186 |
| 21 | HIPK2 | 2.10469452 |
| 22 | TXK | 2.01384803 |
| 23 | AKT3 | 1.96543882 |
| 24 | DDR2 | 1.96145544 |
| 25 | BMPR2 | 1.92057931 |
| 26 | NTRK1 | 1.88859363 |
| 27 | TEC | 1.84057719 |
| 28 | MAP3K3 | 1.82289506 |
| 29 | MAP2K3 | 1.73703509 |
| 30 | JAK3 | 1.66719062 |
| 31 | TGFBR2 | 1.64142696 |
| 32 | FGR | 1.62133352 |
| 33 | STK24 | 1.61230213 |
| 34 | SCYL2 | 1.60075512 |
| 35 | UHMK1 | 1.58549674 |
| 36 | PNCK | 1.55211671 |
| 37 | MAP3K6 | 1.42758915 |
| 38 | JAK1 | 1.39849680 |
| 39 | MAP3K1 | 1.39625661 |
| 40 | MAP2K2 | 1.37041960 |
| 41 | IRAK1 | 1.34674619 |
| 42 | CAMK2D | 1.34059930 |
| 43 | ZAP70 | 1.33515998 |
| 44 | TESK1 | 1.33388227 |
| 45 | ADRBK2 | 1.33281899 |
| 46 | CDC42BPA | 1.30265091 |
| 47 | CHUK | 1.29817908 |
| 48 | CSK | 1.29606616 |
| 49 | PTK6 | 1.26952661 |
| 50 | WNK4 | 1.25334095 |
| 51 | LIMK1 | 1.23576933 |
| 52 | LYN | 1.19680008 |
| 53 | SYK | 1.17755437 |
| 54 | CLK1 | 1.13972862 |
| 55 | MAP3K5 | 1.13515477 |
| 56 | STK10 | 1.10207436 |
| 57 | GRK5 | 1.09137472 |
| 58 | CAMK2B | 1.07989663 |
| 59 | ICK | 1.07722684 |
| 60 | CSNK1G3 | 1.00880273 |
| 61 | BTK | 0.98318926 |
| 62 | MAP2K6 | 0.94820148 |
| 63 | DYRK3 | 0.93750450 |
| 64 | MST4 | 0.91377885 |
| 65 | CSF1R | 0.88400321 |
| 66 | HCK | 0.88122245 |
| 67 | CSNK1A1L | 0.87975984 |
| 68 | PRKD2 | 0.87712003 |
| 69 | TAOK1 | 0.85429842 |
| 70 | MET | 0.84534414 |
| 71 | EPHB1 | 0.84076396 |
| 72 | LCK | 0.82050069 |
| 73 | CSNK1G2 | 0.80427784 |
| 74 | MAP2K1 | 0.79151464 |
| 75 | PAK6 | 0.78562517 |
| 76 | MAP3K11 | 0.78392308 |
| 77 | LATS2 | 0.76703090 |
| 78 | PIM1 | 0.76617983 |
| 79 | BMX | 0.75633954 |
| 80 | PKN1 | 0.73060761 |
| 81 | MARK2 | 0.72854309 |
| 82 | PRKCI | 0.72277033 |
| 83 | PTK2 | 0.72180205 |
| 84 | PAK3 | 0.70325564 |
| 85 | DYRK1B | 0.70323388 |
| 86 | TRIB3 | 0.70035917 |
| 87 | KSR2 | 0.69463606 |
| 88 | ABL2 | 0.68540962 |
| 89 | CSNK1A1 | 0.67507166 |
| 90 | TNK2 | 0.65609710 |
| 91 | DAPK2 | 0.65566404 |
| 92 | ITK | 0.65231798 |
| 93 | FES | 0.63899000 |
| 94 | NTRK3 | 0.63891096 |
| 95 | MARK3 | 0.63766089 |
| 96 | PRKCE | 0.62041896 |
| 97 | ACVR1B | 0.62018273 |
| 98 | GRK7 | 0.61570415 |
| 99 | CSNK1G1 | 0.61471298 |
| 100 | WNK1 | 0.61230285 |
| 101 | CDK12 | 0.61120528 |
| 102 | MAP3K13 | 0.60424558 |
| 103 | CAMK2G | 0.59869927 |
| 104 | BLK | 0.58053721 |
| 105 | NME2 | 0.57575289 |
| 106 | MAPKAPK5 | 0.55373748 |
| 107 | BCR | 0.54278636 |
| 108 | PRKCH | 0.53619396 |
| 109 | CAMK1 | 0.52946322 |
| 110 | MAP3K7 | 0.52815985 |
| 111 | BRD4 | 0.52614945 |
| 112 | SIK3 | 0.52370799 |
| 113 | BRAF | 0.50493921 |
| 114 | ADRBK1 | 0.49400362 |
| 115 | WNK3 | 0.47262188 |
| 116 | MAPK4 | 0.46219745 |
| 117 | IRAK3 | 0.44504482 |
| 118 | PRPF4B | 0.43880222 |
| 119 | OXSR1 | 0.41191297 |
| 120 | PDK1 | 0.41019409 |
| 121 | TYRO3 | 0.40334899 |
| 122 | CDK6 | 0.39587131 |
| 123 | RPS6KB1 | 0.38584428 |
| 124 | LATS1 | 0.38272105 |
| 125 | DAPK3 | 0.36808617 |
| 126 | NUAK1 | 0.36763953 |
| 127 | MAPK7 | 0.36420307 |
| 128 | ILK | 0.35657681 |
| 129 | KIT | 0.35386744 |
| 130 | EIF2AK3 | 0.33942785 |
| 131 | IRAK2 | 0.33927508 |
| 132 | STK39 | 0.33791582 |
| 133 | MATK | 0.32793451 |
| 134 | PRKCQ | 0.32472518 |
| 135 | RET | 0.31793323 |
| 136 | PIK3CA | 0.30883192 |
| 137 | PDGFRA | 0.30460513 |
| 138 | ALK | 0.30169706 |
| 139 | DYRK2 | 0.29837259 |
| 140 | FGFR4 | 0.29076568 |
| 141 | TLK1 | 0.29048010 |
| 142 | EIF2AK2 | 0.28720871 |
| 143 | FGFR3 | 0.28643593 |
| 144 | PRKACA | 0.28582104 |
| 145 | CDK19 | 0.28565961 |
| 146 | EGFR | 0.28096218 |
| 147 | FYN | 0.27952915 |
| 148 | ABL1 | 0.27852901 |
| 149 | INSR | 0.27492952 |
| 150 | RPS6KA2 | 0.26594757 |
| 151 | MAPKAPK2 | 0.25675123 |
| 152 | PRKAA1 | 0.24652863 |
| 153 | RPS6KC1 | 0.23566018 |
| 154 | RPS6KL1 | 0.23566018 |
| 155 | JAK2 | 0.23425759 |
| 156 | EPHA3 | 0.23307489 |
| 157 | TESK2 | 0.23110685 |
| 158 | PDPK1 | 0.22119025 |
| 159 | PAK1 | 0.21982012 |
| 160 | PRKD3 | 0.21849065 |
| 161 | SIK1 | 0.21126777 |
| 162 | SIK2 | 0.20996488 |
| 163 | GSK3A | 0.20807216 |
| 164 | CDK5 | 0.20538837 |
| 165 | PRKCA | 0.20413938 |
| 166 | CAMK2A | 0.20040934 |
| 167 | YES1 | 0.20022189 |
| 168 | CSNK1E | 0.19231113 |
| 169 | PRKCD | 0.18789793 |
| 170 | MAP4K1 | 0.18737670 |
| 171 | PKN2 | 0.17642207 |
| 172 | RPS6KA6 | 0.17630728 |
| 173 | PRKDC | 0.17226253 |
| 174 | FLT3 | 0.16464745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.55151475 |
| 2 | Protein export_Homo sapiens_hsa03060 | 4.58189176 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.40540811 |
| 4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.87782326 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.71119556 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.22435434 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.86542043 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.79934154 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77863223 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.72553594 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.70482007 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.67200456 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.66293042 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.59310121 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.57179851 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55169905 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.51858878 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.45304902 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.41595191 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.40850031 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.39101746 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.38294091 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.34767216 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.25094199 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 2.24546573 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19321593 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16956553 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16146956 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.14991120 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 2.12647235 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05968710 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.96810361 |
| 33 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.91255431 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.85992120 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.84302512 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.83619351 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.71779576 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.68590594 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66108166 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.63643445 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.62709760 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60101206 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59524956 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50155618 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.47001695 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41795059 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.41085397 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33569054 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28072802 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.26032031 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21090272 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19364390 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18550684 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17640288 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.13687726 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11454754 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 1.10193648 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 1.08995144 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 1.08826007 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07731354 |
| 61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07142570 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03403357 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02447757 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01273789 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01240692 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00792231 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 1.00446999 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00200420 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.98751469 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97433466 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96978879 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.95211283 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.95152013 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95000815 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93764418 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.91584755 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91117456 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90915238 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89923503 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85973618 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.84792531 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84562559 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83092279 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81852411 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81434990 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81019669 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80765011 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80662620 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79215663 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78841916 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77359161 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76727458 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75432898 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75010796 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73581753 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70314291 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70070239 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69472439 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68968501 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68030165 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.67971249 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.67620838 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66144366 |
| 104 | ABC transporters_Homo sapiens_hsa02010 | 0.63814184 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.63613253 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62511839 |
| 107 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62124294 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59281482 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58364589 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56554655 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51888647 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.50017103 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48861296 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47473600 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46882932 |
| 116 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45475165 |
| 117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44176977 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43668791 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43500016 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43151705 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42469871 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.42245204 |
| 123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42240079 |
| 124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40431818 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39400696 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.38260813 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38260704 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36807200 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36243149 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36018538 |
| 131 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35097204 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34910756 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.34895658 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34121458 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33322271 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33290878 |
| 137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33205648 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.32908195 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31890734 |
| 140 | Long-term depression_Homo sapiens_hsa04730 | 0.31702353 |
| 141 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31332504 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30340427 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29432618 |
| 144 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29341854 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29205316 |
| 146 | Gap junction_Homo sapiens_hsa04540 | 0.29031028 |
| 147 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28898779 |
| 148 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28852264 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28584572 |
| 150 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28126378 |
| 151 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27112002 |
| 152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26342848 |
| 153 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25413006 |
| 154 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24348897 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.24018926 |
| 156 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23851679 |
| 157 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.21782583 |
| 158 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20783759 |
| 159 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18364902 |
| 160 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17237861 |
| 161 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16590260 |
| 162 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15847039 |
| 163 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.15821250 |
| 164 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.15001006 |
| 165 | Tight junction_Homo sapiens_hsa04530 | 0.14987771 |
| 166 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.14199635 |
| 167 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.13279366 |
| 168 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13144709 |
| 169 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11013296 |
| 170 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10806817 |
| 171 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10572860 |
| 172 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10292853 |
| 173 | Hepatitis C_Homo sapiens_hsa05160 | 0.10267584 |
| 174 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.08243587 |

